Trial by Fire Solutions LLC, a leading eClinical solution provider, has announced 2 new agreements with a US-based drug developer and a CRO subsidiary of an S&P 500 firm to utilize SimpleCTMS to optimize management of their respective global clinical studies.
The drug development company will initially deploy SimpleCTMS for 4 Phase II global studies with over 500 subjects planned. It will bridge the outsourced teams and connect global service providers while enabling immediate data visibility across all study components. The CRO subsidiary will incorporate SimpleCTMS as part of a suite of platformed services used to optimize clinical research opportunities.
“While our new clients incorporate different business models within the life
science industry, they both recognize the benefit in being able to implement a study management solution that bridges together all service providers and stakeholders seamlessly.” states Nancy Cecchettini, Chief Product Officer at Trial By Fire Solutions, developer of SimpleCTMS. “Both of our new clients will be able to implement the SimpleCTMS solution quickly and experience the immediate benefits without needing to employ costly integration teams or endure an extended deployment.”
SimpleCTMS was designed and developed to offer the benefits of a CTMS (Clinical Trial Management System) without the extensive upfront financial and resource commitments associated with traditional enterprise systems or the inherent inefficiencies of worksheet trackers. Offering flexible subscription pricing, SimpleCTMS provides early stage drug developers a scalable and cost effective solution to improve the management, performance and study startup costs associated with clinical trials.